The Seattle Biomedical Research Institute (SBRI) announced that it will collaborate with PATH Malaria Vaccine Initiative (MVI) to accelerate malaria vaccine research by opening a new vaccine testing center in Seattle.
The Human Challenge Center will be built at the Seattle Institute, devoted to testing the safety and efficacy of malaria vaccine candidates in humans. The Center will help meet the growing demand to test new interventions against the malaria parasite.
MVI is a global development program that was created in 1999 with initial financial backing from the Bill & Melinda Gates Foundation.
The purpose of the collaboration is to speed up the process of the effective malaria vaccines to eradicate the parasite.
Malaria vaccine testing has already begun at a second site in the United States, the Walter Reed Army Institute of Research in Maryland, and is also being conducted at labs in England and the Netherlands.
For more science and technology news, please check out http://news.finditt.com/NewsList.aspx?cat=12&wcat=4
